K. Abiraj

Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

Carola H. Ries, Michael A. Cannarile, Sabine Hoves et al. · Cancer Cell · 2014 · 1.4K citations

Medicine, Immunology, Oncology +16

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez-Roca et al. · The Lancet Oncology · 2015 · 363 citations

Medicine, Oncology, Pharmacology +14

PET of Somatostatin Receptor–Positive Tumors Using ⁶⁴Cu- and ⁶⁸Ga-Somatostatin Antagonists: The Chelate Makes the Difference

Melpomeni Fani, Luigi Del Pozzo, K. Abiraj et al. · Journal of Nuclear Medicine · 2011 · 257 citations

Medicine, Nuclear Medicine, Oncology +17

Bombesin Antagonist–Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor–Positive Tumors

K. Abiraj, Rosalba Mansi, Maria‐Luisa Tamma et al. · Journal of Nuclear Medicine · 2011 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Reductive cleavage of azo compounds catalyzed by commercial zinc dust using ammonium formate or formic acid

Shankare Gowda, K. Abiraj, D. Channe Gowda · Tetrahedron Letters · 2002 · 96 citations

Natural Sciences, Chemical Engineering, Chemistry +10